233 related articles for article (PubMed ID: 26452722)
1. Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes.
Lin C; Shi J; Moore A; Khetani SR
Drug Metab Dispos; 2016 Jan; 44(1):127-36. PubMed ID: 26452722
[TBL] [Abstract][Full Text] [Related]
2. Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures.
Davidson MD; Khetani SR
Toxicol Sci; 2020 Apr; 174(2):266-277. PubMed ID: 31977024
[TBL] [Abstract][Full Text] [Related]
3. Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions.
Lin C; Khetani SR
Curr Protoc Toxicol; 2017 May; 72():14.17.1-14.17.23. PubMed ID: 28463419
[TBL] [Abstract][Full Text] [Related]
4. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
Davidson MD; Kukla DA; Khetani SR
Integr Biol (Camb); 2017 Aug; 9(8):662-677. PubMed ID: 28702667
[TBL] [Abstract][Full Text] [Related]
5. Micropatterned Coculture With 3T3-J2 Fibroblasts Enhances Hepatic Functions and Drug Screening Utility of HepaRG Cells.
Ware BR; Liu JS; Monckton CP; Ballinger KR; Khetani SR
Toxicol Sci; 2021 Apr; 181(1):90-104. PubMed ID: 33590212
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
7. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions.
Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
Drug Metab Dispos; 2012 Apr; 40(4):706-16. PubMed ID: 22228749
[TBL] [Abstract][Full Text] [Related]
8. Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver.
Davidson MD; Lehrer M; Khetani SR
Tissue Eng Part C Methods; 2015 Jul; 21(7):716-25. PubMed ID: 25517416
[TBL] [Abstract][Full Text] [Related]
9. Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes.
Davidson MD; Ballinger KR; Khetani SR
Sci Rep; 2016 Jun; 6():28178. PubMed ID: 27312339
[TBL] [Abstract][Full Text] [Related]
10. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
11. Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds.
Schaefer M; Schänzle G; Bischoff D; Süssmuth RD
Drug Metab Dispos; 2016 Mar; 44(3):435-44. PubMed ID: 26712819
[TBL] [Abstract][Full Text] [Related]
12. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
[TBL] [Abstract][Full Text] [Related]
13. Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling.
Ware BR; McVay M; Sunada WY; Khetani SR
Toxicol Sci; 2017 Jun; 157(2):387-398. PubMed ID: 28369597
[TBL] [Abstract][Full Text] [Related]
14. Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures.
Davidson MD; Pickrell J; Khetani SR
Toxicology; 2021 Feb; 449():152662. PubMed ID: 33359713
[TBL] [Abstract][Full Text] [Related]
15. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes.
Smith CM; Nolan CK; Edwards MA; Hatfield JB; Stewart TW; Ferguson SS; Lecluyse EL; Sahi J
J Pharm Sci; 2012 Oct; 101(10):3989-4002. PubMed ID: 22806329
[TBL] [Abstract][Full Text] [Related]
17. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
18. Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450.
Smith S; Lyman M; Ma B; Tweedie D; Menzel K
Drug Metab Dispos; 2021 Nov; 49(11):995-1002. PubMed ID: 34407991
[TBL] [Abstract][Full Text] [Related]
19. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
